Search Results

• • 1,760 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice

  Authors:Vivencio Barrios, Antonio Coca, Carlos Escobar, Rosa Enrique, and Luis Miguel RinconFrom:Expert Review of Cardiovascular Therapy (Vol. 10, Issue 2) Peer-Reviewed

  Feb. 20124,937 words Survey 1370LAuthor(s): Vivencio Barrios [**] 1 , Antonio Coca 2 , Carlos Escobar 3 , Rosa Enrique 4 , Luis Miguel Rincón 5 Keywords : angiotensin-converting enzyme inhibitors; angiotensin receptor blockers; clinical...

• Cost-effectiveness of angiotensin-converting enzyme inhibitors in nondiabetic advanced renal disease

  Authors:Charles Christian Adarkwah and Afschin GandjourFrom:Expert Review of Pharmacoeconomics & Outcomes Research (Vol. 11, Issue 2) Peer-Reviewed

  Apr. 20115,453 words Article 1400LAuthor(s): Charles Christian Adarkwah 1 2 , Afschin Gandjour [[dagger]] 3 4 5 Keywords : advanced renal disease; angiotensin-converting enzyme inhibitors; cost-effectiveness; decision modeling; hypertension...

• FRONT RACE The HOPE trial confirms an ACE inhibitor's effects

  Author:CAROL S. SAUNDERSFrom:Patient Care (Vol. 34, Issue 7) Peer-Reviewed

  Apr. 15, 2000528 words Brief article In a study that received wide attention, researchers with the Heart Outcomes Prevention Evaluation (HOPE) study found that treatment with the angiotensin-converting enzyme (ACE) inhibitor ramipril produces significant...

• Trading glucose control for hypertension: lessons from mother nature

  Author:Robert ChiltonFrom:Clinical Diabetes (Vol. 31, Issue 1) Peer-Reviewed

  Winter 20132,355 words Report 1510LSTUDY Brown N J, Byiers S, Carr D, Maldonado M, Warner BA: Dipeptidyl peptidase-IV inhibitor associated with increased risk of ACE inhibitor-associated angioedema. Hypertension 54:516-523, 2009 SUMMARY...

• Pharmacogenetics of ACE inhibitor-induced angioedema and cough: a systematic review and meta-analysis

  Authors:Seyed Hamidreza Mahmoudpour, Maarten Leusink, Lisa van der Putten, Ingrid Terreehorst, Folkert W Asselbergs, Anthonius de Boer, et al.From:Pharmacogenomics (Vol. 14, Issue 3) Peer-Reviewed

  Feb. 20136,701 words Report 1360LAuthor(s): Seyed Hamidreza Mahmoudpour 1 , Maarten Leusink 1 , Lisa van der Putten 2 , Ingrid Terreehorst 3 , Folkert W Asselbergs 4 , Anthonius de Boer 1 , Anke H Maitland-van der Zee [*] 5 KEYWORDS : ACE I/D;...

• Why take this patient off her ACEI?

  Authors:Puay Hoon Lee, Jamie Wrenn, and Cheryl GilmartinFrom:Clinician Reviews (Vol. 23, Issue 7) Peer-Reviewed

  July 20131,442 words Case study 1720LQ I sent a 68-year-old, hypertensive, diabetic woman with stage 4 kidney disease (estimated glomerular filtration rate [eGFR], 25 mL/min/1.73 [m.sup.2]; serum creatinine [SCr], 2 mg/mL) to a local nephrology group....

• Cognitive enhancing effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on learning and memory

  Authors:V. Nade, L. Kawale, K. Valte, and N. ShendyeFrom:Indian Journal of Pharmacology (Vol. 47, Issue 3) Peer-Reviewed

  May-June 20154,791 words Report 1530LByline: V. Nade, L. Kawale, K. Valte, N. Shendye Objective: The present study was designed to investigate cognitive enhancing property of angiotensin-converting enzymes inhibitors (ACEI) and angiotensin receptor...

• Use of angiotensin-converting enzyme inhibitors immediately after stroke: Commentary

  Author:Subhash KaulFrom:Annals of Indian Academy of Neurology (Vol. 13, Issue 3) Peer-Reviewed

  July-September 2010731 words Report Byline: Subhash. Kaul This issue of Annals of Indian Academy of Neurology features a debate on the controversial topic, 'ACE inhibitors will help in improving stroke outcome if given immediately after stroke'. Dr....

• ARB use in a patient allergic to ACE inhibitors

  Author:Jennifer NiederstadtFrom:Clinical Advisor (Vol. 13, Issue 10)

  Oct. 2010188 words Brief article, Lette... 1150LWould you consider a trial of an angiotensin II receptor blocker (ARB) in a patient who has an ACE inhibitor allergy? The patient has an allergic rash as well as a cough.--JENNIFER NIEDERSTADT, APRN-BC, Franklin, Wisc....

• ACE inhibitors may help prevent cancer

  From:Molecular Diagnosis & Therapy (Vol. 12, Issue 6) Peer-Reviewed

  November-December 2008237 words Brief article, Clini... 1220LResearchers from the Netherlands report that ACE inhibitors and other renin-angiotensin system inhibitors appear to have a protective effect against cancer. They noted that the deletion version of an...

• Are physicians aware of the side effects of angiotensin-converting enzyme inhibitors? * A questionnaire survey in different medical categories

  Authors:Carlo Lombardi, Mariangiola Crivellaro, Annarita Dama, Gianenrico Senna, Sabrina Gargioni, and Giovanni PassalacquaFrom:Chest (Vol. 128, Issue 2) Peer-Reviewed

  Aug. 20051,687 words Article Study objective: Angiotensin-converting enzyme inhibitors (ACE-I) are considered safe, but they are associated with characteristic side effects, namely cough and angioedema, usually requiring discontinuation. We...

• Aortic ruptures less common in people on ACE inhibitor drugs

  From:Nursing Standard (Vol. 21, Issue 6) Peer-Reviewed

  Oct. 18, 2006225 words Brief article 1670LAngiotensin-converting enzyme (ACE) inhibitors are associated with a reduced risk of ruptured abdominal aortic aneurysm, unlike other antihypertensive agents. Abdominal aortic aneurysm affects 4-8 per cent of men and...

• ACE inhibitors: in the fourth of this series on drugs and therapeutics, Charlotte Nicholls and Mojgan Sani discuss the use of ACE inhibitors, used to treat hypertension and heart failure

  Authors:Charlotte Nicholls and Mojgan SaniFrom:Nursing Older People (Vol. 16, Issue 2) Peer-Reviewed

  Apr. 20041,725 words Article The development of angiotensin converting enzyme (ACE) inhibitors arose from the discovery of converting enzyme inhibitors in the venom of the South American pit viper (Bothrops jararaca). Through the study of these...

• Use of ramipril in preventing stroke: double blind randomised trial. (Papers)

  Authors:Jackie Bosch, Salim Yusuf, Janice Pogue, Peter Sleight, Eva Lonn, Badrudin Rangoonwala, et al.From:British Medical Journal (Vol. 324, Issue 7339) Peer-Reviewed

  Mar. 23, 20022,615 words Article The ACE inhibitor ramipril can lower the risk of stroke in patients with risk factors for stroke, according to a study of 9,297 people. The drug lowered the risk of stroke by 32% even though it did not lower blood...

• Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction

  Authors:James Mason, Philip Young, Nick Freemantle, and Richard HobbsFrom:British Medical Journal (Vol. 321, Issue 7269) Peer-Reviewed

  Nov. 4, 20003,473 words Article ACE inhibitors may be cost-effective in treating heart failure, according to a study of 7,487 patients. Many doctors don't use ACE inhibitors for these patients based on fears of side effects such as low blood pressure...

• Taking precautions with ACE inhibitors: a theoretical risk exists in patients with unilateral renal artery stenosis

  Authors:A. Kumar, M. Asim, and A.M. DavisonFrom:British Medical Journal (Vol. 316, Issue 7149) Peer-Reviewed

  June 27, 1998982 words Editorial A theoretical risk exists in patients with unilateral renal artery stenosis Angiotensin converting enzyme inhibitors have revolutionised the treatment of congestive heart failure,[1] hypertension,[2] and diabetic...

• The effects of preoperative therapy with angiotensin-converting enzyme inhibitors on clinical outcome after cardiovascular surgery

  Authors:Mohamed Y. Rady and Thomas RyanFrom:Chest (Vol. 114, Issue 2) Peer-Reviewed

  Aug. 19984,721 words Article Objective: To determine the effect of preoperative therapy with angiotensin-converting enzyme (ACE) inhibitors on clinical outcome after cardiovascular surgery. Study: Inception cohort. Setting: A tertiary care 54-bed...

• ACE Inhibitors Slow Renal Disease Progress

  Author:MITCHEL L. ZOLERFrom:Family Practice News (Vol. 29, Issue 19)

  Oct. 1, 1999382 words Article TOR0NT0 -- Angiotensin-converting enzyme inhibitors appeared to slow renal disease in African Americans with diabetic nephropathy, Dr. Errol D. Crook reported at a meeting of the International Society on Hypertension in...

• Prevention and regression of coronary athersclerosis: is it safe and efficacious therapy?

  Authors:Terrence Montague, Ross Tsuyuki, Jeffrey Burton, Randall Williams, Vladimir Dzavik, and Koon TeoFrom:Chest (Vol. 105, Issue 3) Peer-Reviewed

  Mar. 19945,857 words Article Objective: Atherosclerotic coronary heart disease (CHD) continues to be the dominant disease in Western society. A large body of evidence directly linking serum cholesterol levels and CHD risk has stimulated population...

• Angiotensin converting enzyme inhibition reduces cardiovascular responses to acute stress in myocardially infarcted and chronically stressed rats

  Authors:A. Cudnoch-Jedrzejewska, K. Czarzasta, L. Puchalska, J. Dobruch, O. Borowik, J. Pachucki, et al.From:BioMed Research InternationalPeer-Reviewed

  Annual 20146,218 words Report 1430LPrevious studies showed that chronically stressed and myocardially infarcted rats respond with exaggerated cardiovascular responses to acute stress. The present experiments were designed to elucidate whether this effect...